Cutera Inc.: Business Overview, Financials & Competitive Analysis
Cutera Inc. scores 3/10 on the AskCyborg Cyborg Score (Challenged). Cutera operates in a high-growth aesthetic device market but faces severe financial stress requiring fundamental operational restructuring. The company reported a net loss of $39M on $32.5M revenue (TTM basis) with a negative net profit margin of -120% and operating margin of -111%. Cutera announced voluntary delisting from Nasdaq (March.
What is Cutera Inc.'s industry? Cutera Inc. (cutera.com) operates in Medical Devices. AskCyborg classifies Cutera Inc. under Medical Devices in its company registry.
Cutera Inc. designs, develops, manufactures, and services energy-based medical aesthetic systems using advanced ND:YAG technology to address skin resurfacing, acne treatment, body contouring, and hair removal. The com...
Cyborg Score thesis
Cutera operates in a high-growth aesthetic device market but faces severe financial stress requiring fundamental operational...
Read the full analyst-debate transcript →Get the Latest Cutera Inc. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeCutera Inc. Overview
Pro stress-test →Cutera Inc. designs, develops, manufactures, and services energy-based medical aesthetic systems using advanced ND:YAG technology to address skin resurfacing, acne treatment, body contouring, and hair removal. The company distributes its systems globally and operates in the rapidly growing dermatology devices market.
Strategic Profile
Pro stress-test →Cutera maintains a global footprint with direct sales teams in North America, Europe, and Japan, distributing products in over 65 countries. Key flagship products include AviClear (the first FDA-cleared energy device for acne treatment), Secret RF (fractional RF microneedling), and excel V+ (vascular and pigmentary treatment platform).
Competitive Landscape
Pro stress-test →Cutera competes in the medical aesthetic devices segment against established dermatology equipment manufacturers. The market is fragmented with competitors offering laser, light-based, and radiofrequency systems. Key competitive advantages are Cutera's FDA-cleared flagship products (particularly AviClear for acne) and global distribution network, though the company faces intensifying competition and pricing pressure in the growing aesthetic market.
Industry Context
Cutera Inc. operates in Medical Devices.
Key facts
Founded: 1998 · Headquarters: Brisbane, California, US · Revenue: $32.5M · Market cap: $8.6M